Desmoplastic Small Round Cell Tumor Overview
Learn About Desmoplastic Small Round Cell Tumor
- Desmoplastic small round cell tumor
- DSRCT
- Desmoplastic small round-cell tumor
Kootenai Health Inc
Paul White is a Hematologist Oncology specialist and an Oncologist in Sandpoint, Idaho. Dr. White and is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. His top areas of expertise are Desmoplastic Small Round Cell Tumor, Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Familial Pancreatic Cancer, and Bone Marrow Transplant. Dr. White is currently accepting new patients.
Kalispell Regional Medical Center Inc
Jose Ness is an Oncologist and a Geriatrics provider in Eureka, Montana. Dr. Ness and is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. His top areas of expertise are Paget Disease of the Breast, Lymphofollicular Hyperplasia, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Ness is currently accepting new patients.
American Oncology Partners PA
Arvind Chaudhry is a Hematologist Oncology specialist and a Hematologist in Spokane Valley, Washington. Dr. Chaudhry and is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Chaudhry is currently accepting new patients.
Aims: 1. To evaluate the safety and efficacy of GD2/B7H3 CAR-T therapy for relapsed/refractory neuroblastoma, and observe its pharmacokinetic/pharmacodynamic characteristics and the survival of CAR-T cells in relapsed/refractory neuroblastoma patients. 2. To evaluate the safety and efficacy of GD2/B7H3 CAR-T therapy for relapsed/refractory desmoplastic small round cell tumor, and observe its pharmacokin...
Summary: The purpose of this study is to find out if a drug called lurbinectedin (the study drug) is safe and effective at treating people with recurrent or relapsed solid tumors, including Ewing sarcoma.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center